ANTABIO

Antabio is a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens with a particular focus on life-threatening respiratory infections... We are a private biopharmaceutical company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO.

VAT numbers: FR94517511291

Primary location: Labège France